These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16565472)

  • 1. Advanced drug delivery systems that target the vascular endothelium.
    Ding BS; Dziubla T; Shuvaev VV; Muro S; Muzykantov VR
    Mol Interv; 2006 Apr; 6(2):98-112. PubMed ID: 16565472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium.
    Muzykantov VR
    Expert Opin Drug Deliv; 2005 Sep; 2(5):909-26. PubMed ID: 16296786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of anti-platelet-endothelial cell adhesion molecule single-chain variable fragment-urokinase fusion protein to the cerebral vasculature lyses arterial clots and attenuates postischemic brain edema.
    Danielyan K; Ding BS; Gottstein C; Cines DB; Muzykantov VR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):947-52. PubMed ID: 17389242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.
    D'Souza GG; Weissig V
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1135-48. PubMed ID: 19708822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging.
    Pasqualini R; Moeller BJ; Arap W
    Semin Thromb Hemost; 2010 Apr; 36(3):343-51. PubMed ID: 20490984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-endothelial cell adhesion molecule-1-directed endothelial targeting of superoxide dismutase alleviates oxidative stress caused by either extracellular or intracellular superoxide.
    Shuvaev VV; Tliba S; Nakada M; Albelda SM; Muzykantov VR
    J Pharmacol Exp Ther; 2007 Nov; 323(2):450-7. PubMed ID: 17712041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
    Juillerat-Jeanneret L; Schmitt F
    Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of therapeutics to endothelium.
    Simone E; Ding BS; Muzykantov V
    Cell Tissue Res; 2009 Jan; 335(1):283-300. PubMed ID: 18815813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals.
    Muro S; Muzykantov VR; Murciano JC
    Methods Mol Biol; 2004; 283():21-36. PubMed ID: 15197300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug carriers for vascular drug delivery.
    Koren E; Torchilin VP
    IUBMB Life; 2011 Aug; 63(8):586-95. PubMed ID: 21766415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating IgSF proteins inhibit adhesion of antibody targeted microspheres to endothelial inflammatory ligands.
    Kerby MB; Urban JC; Mouallem L; Tripathi A
    Appl Biochem Biotechnol; 2009 Oct; 159(1):208-20. PubMed ID: 19140030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.
    Kowalski PS; Leus NG; Scherphof GL; Ruiters MH; Kamps JA; Molema G
    IUBMB Life; 2011 Aug; 63(8):648-58. PubMed ID: 21766413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in strategies to improve drug delivery to brain tumors.
    Newton HB
    Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting urokinase-type plasminogen activator and its receptor for cancer therapy.
    Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Ohara T; Yamamoto E
    Anticancer Drugs; 2006 Nov; 17(10):1109-17. PubMed ID: 17075310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.
    Kim YI; Chung JW
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):791-802. PubMed ID: 19090739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting antioxidant and antithrombotic biotherapeutics to endothelium.
    Carnemolla R; Shuvaev VV; Muzykantov VR
    Semin Thromb Hemost; 2010 Apr; 36(3):332-42. PubMed ID: 20490983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted endothelial nanomedicine for common acute pathological conditions.
    Shuvaev VV; Brenner JS; Muzykantov VR
    J Control Release; 2015 Dec; 219():576-595. PubMed ID: 26435455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.